144 related articles for article (PubMed ID: 8361584)
1. Prenatal cocaine exposure: decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring.
Byrnes JJ; Pritchard GA; Koff JM; Miller LG
Neuropharmacology; 1993 Jul; 32(7):721-3. PubMed ID: 8361584
[TBL] [Abstract][Full Text] [Related]
2. Prenatal cocaine exposure: increased striatal dopamine transporter binding in offspring at 3 and 6 months of age.
Koff JM; Miller LG
Brain Res Bull; 1994; 33(2):223-4. PubMed ID: 8275343
[TBL] [Abstract][Full Text] [Related]
3. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding.
Koff JM; Shuster L; Miller LG
J Pharmacol Exp Ther; 1994 Jan; 268(1):277-82. PubMed ID: 8301568
[TBL] [Abstract][Full Text] [Related]
4. Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites.
Itzhak Y; Martin JL
Brain Res; 1999 Feb; 818(2):204-11. PubMed ID: 10082805
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
Collins LM; Meyer JS
Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
[TBL] [Abstract][Full Text] [Related]
6. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
Choi SJ; Mazzio E; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
[TBL] [Abstract][Full Text] [Related]
7. Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum.
Salvatore MF; Hudspeth O; Arnold LE; Wilson PE; Stanford JA; MacTutus CF; Booze RM; Gerhardt GA
Neuroscience; 2004; 123(2):481-90. PubMed ID: 14698755
[TBL] [Abstract][Full Text] [Related]
8. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
Meiergerd SM; McElvain JS; Schenk JO
Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry.
McElvain JS; Schenk JO
Ann N Y Acad Sci; 1992 Jun; 654():480-2. PubMed ID: 1632608
[No Abstract] [Full Text] [Related]
10. Cocaine causes a time dependent and dose dependent increase in D1 receptors and dopamine transporters.
Wamsley JR; Alburges ME
Proc West Pharmacol Soc; 1993; 36():277-82. PubMed ID: 8378389
[No Abstract] [Full Text] [Related]
11. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
12. The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration.
Meiergerd SM; Hooks SM; Schenk JO
J Neurochem; 1994 Oct; 63(4):1277-81. PubMed ID: 7931279
[TBL] [Abstract][Full Text] [Related]
13. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633
[TBL] [Abstract][Full Text] [Related]
14. Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909.
Pögün S; Scheffel U; Kuhar MJ
Eur J Pharmacol; 1991 Jun; 198(2-3):203-5. PubMed ID: 1864307
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
Cline EJ; Scheffel U; Boja JW; Carroll FI; Katz JL; Kuhar MJ
J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
17. Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function.
Leslie CA; Robertson MW; Jung AB; Liebermann J; Bennett JP
Synapse; 1994 Jul; 17(3):210-5. PubMed ID: 7974205
[TBL] [Abstract][Full Text] [Related]
18. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors.
Bezard E; Dovero S; Belin D; Duconger S; Jackson-Lewis V; Przedborski S; Piazza PV; Gross CE; Jaber M
J Neurosci; 2003 Dec; 23(35):10999-1007. PubMed ID: 14657156
[TBL] [Abstract][Full Text] [Related]
19. Medial dorsal striatum is more sensitive than lateral dorsal striatum to cocaine inhibition of exogenous dopamine clearance: relation to [3H]mazindol binding, but not striosome/matrix.
Cline EJ; Adams CE; Larson GA; Gerhardt GA; Zahniser NR
Exp Neurol; 1995 Jul; 134(1):135-49. PubMed ID: 7672034
[TBL] [Abstract][Full Text] [Related]
20. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
